Page 51 - IMO-1-1
P. 51

Innovative Medicines & Omics                                         Antioxidant nanomedicines for therapies



            acid and edetate calcium disodium were used in clinic for   while CeO  nanoparticles catalyze antioxidation reactions
                                                                        2
            eliminating Pb ions, but suffer from low selectivity and side   to alleviate oxidative damage, synergistically elevating the
            effects.  Natural bacteria have presented high performances   therapeutic efficacy of Pb poisoning.
                 498
            in  adsorption  of  heavy  metal,   and  Pan  et al.  further
                                     499
            constructed  a  bacteria-based  bioreactor  for  concurrent   Although the applications of antioxidant nanomedicines
                                                     500
            Pb ion adsorption and ROS scavenging (Figure 40).  The   for the treatment of these diseases are in their early stage
            bioreactor was fabricated by decorating CeO  nanoparticles   (Table 10), it is expected that more advances will be made
                                               2
            on a nonpathogenic bacteria  Escherichia coli MG1655,   in the future by constructing new versatile antioxidant
            which can accumulate in Pb-rich organs to absorb Pb ions,   nanomedicines.


            Table 10. Summary of representative antioxidant nanomedicines for the treatment of other diseases
            Antioxidant nanomedicine                  Reaction type       Disease                     References
            Zr-doped CeO  nanoparticle                Catalytic           Sepsis                        452
                      2
            Single-atom Co nanocatalyst               Catalytic           Sepsis                        454
            WS  nanosheet                             Catalytic           Sepsis                        455
              2
            Mn O  nanoparticle                        Catalytic           Spinal cord injury            460
              3  4
            MnO  nanoparticle embedded in a hydrogel  Catalytic           Spinal cord injury            463
                2
            CeO  nanoparticle in a nanofiber bundle scaffold  Catalytic   Tendon injury                 466
               2
            Polydopamine nanoparticle                 Non-catalytic       Periodontal disease           46
            Epigallocatechin gallate-based nanoparticle  Non-catalytic    Periodontal disease           469
            CeO  nanoparticle in orofacial prosthesis  Catalytic          Nasopalatal defect            472
               2
            CeO  nanoparticle with bovine serum albumin  Catalytic        Depression                    478
               2
            Bilirubin nanomedicine                    Non-catalytic       Acute pancreatitis            484
            Prussian blue nanoparticle                Catalytic           Acute pancreatitis            485
            Nb C nanosheet                            Non-catalytic       Ionizing irradiation injury   489
              2
            Melanin nanoparticle                      Noncatalytic        Ionizing irradiation injury   490
            Prussian blue nanoparticle                Catalytic           Ionizing irradiation injury   491
            CeO  nanoparticle                         Catalytic           Ionizing irradiation injury   492
               2
            Mn O /CeO  nanoparticle                   Catalytic           Ionizing irradiation injury   493
              3  4  2
            CeO  nanoparticle on Escherichia coli MG1655  Catalytic       Heavy metal poisoning         500
               2























            Figure 40. Schematic illustration of heavy metal poisoning protection using a bacteria-based bioreactor. Reproduced with permission from Pan et al.
                                                                                                            500
            Copyright © 2019, Wiley-VCH.

            Volume 1 Issue 1 (2024)                         45                               doi: 10.36922/imo.2527
   46   47   48   49   50   51   52   53   54   55   56